AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...
One chief equity strategist says that the S&P 500 Index could face a significant decline next year following its 2024 gains.
UBS Global Research on Tuesday raised its year-end target for the benchmark S&P 500 index to 5,850 points from an earlier ...
The S&P 500 advanced 0.8% on Monday, adding to the benchmark index's all-time high Friday for a second straight record close.
The S&P 500 index was up slightly Wednesday, with sector gains led by utilities and financials, according to FactSet data, at last check. The utilities sector was up 1.1% Wednesday morning, while the ...
Charles Schwab ( SCHW) shares jumped 6.1% after the brokerage firm posted its results for the third quarter, exceeding ...
Short interest for healthcare stocks in S&P 500 increased during September end vs. last month, with Moderna being most ...
MicroStrategy stock has outperformed all S&P 500 firms since 2020, but despite its robust performance, a listing in the index ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
The S&P 500 and the Dow scored record closing highs on Friday, with the big boosts from financial stocks after banks reported ...
The S&P 500 finished the week ending October 11 with another record-breaking rally, up 0.97% from last Friday.
But for many investors, S&P 500 index funds remain the overwhelming favorite when it comes to long-term investing. The S&P 500 index tracks the prices of the 500 largest U.S. public companies ...